Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial.

Onderzoeksoutput: Poster

Originele taal-2English
StatusPublished - 2121
EvenementESMO CONGRES -
Duur: 16 sep 202121 sep 2021

Conference

ConferenceESMO CONGRES
Periode16/09/2121/09/21

Citeer dit